machine learning
Events/ Insights/ Reuters Pharma 2022/ Sales and Marketing/ Views and analysis
A Reuters Pharma conversation with EY: smart reviewing and payment outcomes
Nicole Raleigh
AI, data, EY Consulting, health outcomes, machine learning, patient centricity, payment outcomes, pharma, Reuters Pharma, Smart Reviewer
0 Comment
Digital/ R&D/ Views & Analysis/ Views & Analysis/ Views and analysis
Artificial Intelligence for better antibody drugs: ready for prime time?
mike.hammerton@pharmaphorum.com
AI, biopharma, data, deep leaning, discovery, hit identification, hit optimisation, mAbs, machine learning, monoclonal antibodies
0 Comment
Digital/ News/ News/ News/ R&D
GSK turns to AI specialist Tempus for R&D productivity boost
Phil Taylor
artificial intelligence, clinical trials, drug discovery, GlaxoSmithKline, machine learning, partnering, Target Discovery, Tempus
0 Comment
Digital/ News/ News/ Oncology/ R&D
Odyssey Therapeutics $168 million Series B financing oversubscribed
Nicole Raleigh
AI, General Catalyst, immunology, Innovation, machine learning, Odyssey Therapeutics, Oncology, Series B financing
0 Comment
Digital/ Views & Analysis/ Views and analysis
Transforming oncology outcomes through data and digital
mike.hammerton@pharmaphorum.com
AI, customer experience, data, digital health, machine learning, Takeda
0 Comment
Merck launches accelerator programme for AI startups
Phil Taylor
accelerator, artificial intelligence, digital, digital health, Drug Discovery & Development, machine learning, Merck & Co
0 Comment
Boehringer backs AI-powered anti-infective startup ArrePath
Phil Taylor
anti-infectives, antimicrobial resistance, ArrePath, artificial intelligence, digital, digital health, financing, machine learning
0 Comment
Bayer-led project on AI in trials eyes ‘virtual’ placebo groups
Phil Taylor
Aalto University, artificial intelligence, Bayer, clinical trials, Finland, Helsinki University Hospital, machine learning
0 Comment